Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Navigating Tapestry Analyst Insights and Projections

Elaine Mendonca by Elaine Mendonca
February 29, 2024
in Breaking News
0
Technology Cloud computing Trading online
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

Unraveling the Tapestry: Analyst Perspectives and Projections

Over the past few months, analysts have shared a diverse range of opinions on Tapestry (NYSE:TPR), from optimistic to cautious. Here’s a snapshot of recent analyst insights and ratings:

– One analyst remains bullish on Tapestry, with their rating unchanged from a month ago.
– Six analysts are somewhat bullish, with no recent adjustments.
– Two analysts are indifferent, with one rating updated in the last 30 days.
– There have been no recent ratings in the somewhat bearish or bearish categories.

Looking at price targets, the average 12-month forecast for Tapestry is $48.44, ranging from a high of $60.00 to a low of $38.00. This represents a 20.35% increase from the previous average of $40.25.

Key analyst actions include:

– Ashley Helgans from Jefferies maintaining a “Hold” rating with a price target of $50.00.
– Brooke Roach at Goldman Sachs upgrading the rating to “Buy” with a price target of $47.00.
– Michael Binetti from Evercore ISI Group raising the rating to “Outperform” with a price target of $50.00.
– Ike Boruchow at Wells Fargo increasing the rating to “Overweight” with a price target of $60.00.
– Rick Patel from Raymond James upgrading the rating to “Outperform” with a price target of $44.00.
– Alexandra Steiger at Morgan Stanley maintaining an “Equal-Weight” rating with a price target of $38.00.

In addition to these insights, various sources like TipRanks, Nasdaq, MarketBeat, The Wall Street Journal, and MarketScreener offer further analysis on Tapestry’s stock forecast, analyst predictions, consensus ratings, and price targets. Notably, Tapestry has garnered an overall consensus rating of “Strong Buy” based on positive outlooks and buy ratings from analysts.

For a more in-depth look at individual analyst recommendations and historical stock performance, investors can consult these sources for a comprehensive understanding of Tapestry’s market position and potential investment opportunities.

Tapestry Inc. (TPR) Stock Market Performance Analysis – February 29, 2024

On February 29, 2024, Tapestry Inc. (TPR) showed a mixed performance in the stock market. TPR is currently trading near the top of its 52-week range and above its 200-day simple moving average, indicating a positive trend in the stock’s price momentum. However, on that particular day, TPR shares experienced a slight decrease in price. The stock opened at $47.42, which was $0.30 lower than its previous close. Throughout the trading day, the price of TPR shares dropped by $0.01, representing a 0.02% decrease from the previous closing price. While a small drop in price may not seem significant, it is essential for investors to closely monitor any fluctuations in stock prices. In this case, the slight decrease in TPR’s share price on February 29th could be attributed to various factors such as market volatility, economic indicators, or company-specific news. Investors and analysts will continue to keep a close eye on Tapestry Inc.’s stock performance in the coming days to assess whether the slight drop in price was an isolated event or part of a larger trend. It is important for investors to conduct thorough research and analysis before making any investment decisions.

Tapestry Inc. (TPR) Reports Strong Financial Results, Stock Surges on February 29, 2024

On February 29, 2024, Tapestry Inc. (TPR) saw a significant increase in its stock performance following the release of its financial results. Total revenue for the past year was $6.66 billion, remaining flat compared to the previous year but increasing by 37.75% since the last quarter to $2.08 billion.

Net income for the past year was $936.00 million, showing a 9.31% increase compared to the previous year, with second-quarter net income at $322.30 million, reflecting a substantial 65.28% increase since the last quarter.

Earnings per share (EPS) for the past year stood at $3.88, marking a 22.35% increase from the previous year, and second-quarter EPS was $1.39, showing a remarkable 65.85% increase since the last quarter.

Investors reacted positively to these results, leading to a surge in TPR stock prices on February 29, 2024. The strong performance in revenue, net income, and EPS demonstrated the company’s ability to drive growth and profitability despite challenging market conditions. This positive momentum bodes well for Tapestry Inc. as it continues to execute its strategic initiatives and expand its market presence. TPR stock showed strong performance on February 29, 2024, reflecting the company’s solid financial results and investor confidence in its future prospects.

Tags: TPR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Tegna Reports Lower Than Expected Quarterly Financial Results

Healthcare-IT-and-tech

Title Nanox and Beilinson Hospital Collaborate on Advanced Imaging for Lung and Chest Diseases

Analyzing Analyst Perspectives Jazz Pharmaceuticals Forecast

Recommended

Biotechnology Market Capitalization

Analyst Upgrades Price Target for Nuvation Bio to 5

2 years ago
CryoLife Stock

Medical Device Specialist Artivion Maintains Strong Analyst Backing

3 months ago
Walgreens Boots Alliance Stock

Walgreens Concludes Public Trading Era Following Landmark Acquisition

3 months ago
MA stock news

Analysis of Short Interest and Financial Performance of US Bancorp

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Procter & Gamble Shares Approach a Critical Juncture

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

Palantir Shares: A Wall Street Divide and a Bold New Price Target

Trending

Eli Lilly Stock
AI & Quantum Computing

Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

by Felix Baarz
January 11, 2026
0

Eli Lilly and Company has opened 2026 with a clear strategic push to diversify and strengthen its...

Alibaba Stock

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

January 11, 2026
Vulcan Energy Stock

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

January 11, 2026
Viking Therapeutics Stock

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

January 11, 2026
Astera Labs Stock

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances
  • Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs
  • Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com